Free tool
FTDZX and BBH: how much do they overlap?
Enter any two ETFs or mutual funds to see how much of their portfolios overlap, using each fund's latest SEC holdings report.
Bottom line
Overlap between FTDZX and BBH
40% of their top holdings overlap by weight, with 8 securities in common among each fund's top 25. They share a meaningful core but differ in the rest of the portfolio. Note that FTDZX holds far more positions (126 vs 25), so it is broader beyond the top names.
| Holding | % of FTDZX | % of BBH |
|---|---|---|
| Amgen, Inc. | 4.39% | 15.25% |
| Gilead Sciences, Inc. | 3.86% | 12.79% |
| Regeneron Pharmaceuticals, Inc. | 3.77% | 6.21% |
| Argenx SE | 3.62% | 4.97% |
| Vertex Pharmaceuticals, Inc. | 3.54% | 9.10% |
| Revolution Medicines, Inc. | 3.01% | 5.27% |
| Insmed, Inc. | 1.99% | 2.67% |
| Neurocrine Biosciences, Inc. | 1.82% | 2.08% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Popular overlap checks
| Pair | Overlap | |
|---|---|---|
| VOO vs VTI | 99% | Details |
| QQQ vs VGT | 57% | Details |
| SCHD vs VYM | 24% | Details |
| VOO vs QQQ | 68% | Details |
| VTI vs VXUS | 0% | Details |
| VUG vs QQQ | 69% | Details |
| JEPI vs SCHD | 2% | Details |
Source: SEC Form N-PORT; top-25 holdings, weight-normalized